Notably, a ten-fold increase of the concentrations of the epithelial committed cancer stem cell-derived EV subpopulation (CD133+/CD326+) was detected in lung cancer patients, when compared to healthy subjects, although such a subset did not significantly change between all cancer patients and healthy controls. This evidence concerns the gene PROM1 and lung cancer.